Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Antimicrob Agents Chemother ; 40(7): 1589-93, 1996 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8807045

RESUMO

Using two strains of Salmonella enteritidis, one susceptible and one resistant to ampicillin, we studied the efficacies of ampicillin, gentamicin, ampicillin plus gentamicin, ofloxacin, and cefotaxime for the treatment of experimental salmonella endocarditis. Rabbits were treated for 3 days with dosages of antibiotic selected to achieve concentrations in serum equivalent to those obtained in humans during therapy. Aortic salmonella endocarditis seemed to be very difficult to treat, and all antimicrobial regimens failed to achieve the complete sterilization of cardiac vegetations. In vitro studies did not accurately predict the in vivo response to therapy, and no correlations regarding the synergistic activity of the combination of ampicillin plus gentamicin were observed. For the ampicillin-susceptible S. enteritidis isolate, ampicillin and cefotaxime produced the greatest reduction in the number of organisms in vegetations, with no significant differences between them. For the ampicillin-resistant strain, the combination of ampicillin with gentamicin produced a synergistic effect that was not anticipated by the in vitro studies. Both cefotaxime and ofloxacin were effective in reducing the number of microorganisms in the vegetations, although the reduction produced by cefotaxime was less that that produced against the ampicillin-susceptible strain. Monotherapy with gentamicin exhibited only modest activity against the ampicillin-susceptible S. enteritidis strain.


Assuntos
Resistência a Ampicilina , Ampicilina/farmacologia , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Cefotaxima/farmacologia , Endocardite Bacteriana/tratamento farmacológico , Endocardite Bacteriana/microbiologia , Gentamicinas/farmacologia , Ofloxacino/farmacologia , Infecções por Salmonella , Salmonella enteritidis/efeitos dos fármacos , Animais , Humanos , Testes de Sensibilidade Microbiana , Coelhos
3.
Antimicrob Agents Chemother ; 38(5): 1103-6, 1994 May.
Artigo em Inglês | MEDLINE | ID: mdl-8067745

RESUMO

Using two strains of pneumococci for which MICs of penicillin were 1 and 4 micrograms/ml, those of cefotaxime were 0.01 and 0.5 micrograms/ml, and those of teicoplanin were 0.01 and 0.1 micrograms/ml, we studied the efficacy of different dosages of penicillin, cefotaxime, and teicoplanin in the treatment of experimental pneumococcal endocarditis in rabbits. Animals treated with dosages of penicillin G procaine needed to achieve levels in serum near the MIC for pneumococci showed a significant reduction in log10 CFU per gram of vegetation, as compared with the control (P < 0.001), although only 20% of the animals showed sterile vegetations. When levels of penicillin in serum were in the range of three- to fourfold the MIC, a greater reduction in log10 CFU per gram of vegetation was seen, and 88% of the animals showed sterile vegetations. Only the regimen of penicillin that provided concentrations in serum above the MIC throughout the interval between two doses provided constant sterilization of the cardiac vegetations. Dosages of cefotaxime and teicoplanin selected to achieve concentrations in serum equivalent to that obtained in humans during treatment resulted in levels of antimicrobial agents in serum hundreds or thousands of times higher than the MICs for the infecting strains. In terms of antimicrobial efficacy, cefotaxime and teicoplanin were equivalent to regimens with high dosages of penicillin.


Assuntos
Antibacterianos/uso terapêutico , Endocardite Bacteriana/tratamento farmacológico , Infecções Pneumocócicas/tratamento farmacológico , Animais , Antibacterianos/sangue , Endocardite Bacteriana/microbiologia , Cinética , Testes de Sensibilidade Microbiana , Resistência às Penicilinas , Infecções Pneumocócicas/microbiologia , Coelhos , Streptococcus pneumoniae/efeitos dos fármacos
4.
Rev Clin Esp ; 193(6): 322-8, 1993 Oct.
Artigo em Espanhol | MEDLINE | ID: mdl-8259458

RESUMO

Cryptosporidiosis is a coccidian infection that usually occurs in children an immunocompromised patients. With the AIDS (Acquired Immunodeficiency Syndrome) epidemic there have been an increased number of clinical cases and still we don't have an optimal therapeutic regimen to eradicate the infection. Since 1907 when the organism was first described, a large amount of anti-infective agents have been used without success. We present herein a review of the new therapeutic approaches, although none of them is satisfactory and new studies are required for the development of an optimal treatment. Symptomatic and nutritional support are the unique treatment we have so far.


Assuntos
Coccidiostáticos/uso terapêutico , Criptosporidiose/terapia , Adenina/análogos & derivados , Adenina/uso terapêutico , Amprólio/uso terapêutico , Animais , Azitromicina/uso terapêutico , Colostro/imunologia , Eflornitina/uso terapêutico , Humanos , Imunoglobulinas , Espiramicina/uso terapêutico , Fator de Transferência/uso terapêutico , Zidovudina/uso terapêutico
5.
J Clin Microbiol ; 24(3): 472-3, 1986 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-3760141

RESUMO

A case of pyogenic meningitis caused by Bacteroides fragilis in a 72-year-old woman is reported. Although the isolate was susceptible to thiamphenicol, the patient did not respond to this drug. Metronidazole, which showed high bactericidal activity, was administered and achieved sterilization of the cerebrospinal fluid and complete clinical response.


Assuntos
Infecções por Bacteroides/tratamento farmacológico , Meningite/tratamento farmacológico , Metronidazol/uso terapêutico , Tianfenicol/uso terapêutico , Idoso , Infecções por Bacteroides/líquido cefalorraquidiano , Bacteroides fragilis/efeitos dos fármacos , Feminino , Humanos , Meningite/líquido cefalorraquidiano , Metronidazol/líquido cefalorraquidiano , Testes de Sensibilidade Microbiana , Úlcera por Pressão/complicações , Úlcera por Pressão/microbiologia , Tianfenicol/líquido cefalorraquidiano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA